Ozempic, Wegovy, Rybelsys, and other forms of Semaglutide drugs (including Tirzepatide) are insanely popular and effective at helping people lose weight.
Studies show Semaglutide causes an average of 15% body weight loss, and that could be massively beneficial for a cyclist.
But what about the risks? It’s still a relatively new drug, so the long term risks remain unknown, but the known risks of gastric distress, including slowed gastric emptying, the negative impact on hunger signals could be disastrous for cyclists and push them into an energy deficiency.
Additionally, there is conflicting evidence in the literature concerning whether Semaglutide causes an inordinate amount of lean mass loss compared to situations where the same amount of weight is lost without the use of Semaglutide. However, if it does cause excessive lean mass loss, again, this drug seems highly risky to take for a cyclist.
But all of that said, power-to-weight ratios are the largest determinant of performance in cycling, and this drug could be hugely beneficial in making cyclists faster.
And for some reason, nobody is talking about how athletes could be using this very expensive drug to improve their performance, and most shocking, is that as of recording this video, it is an approved substance by WADA, the World Anti-Doping Agency.
At $1,000-2,000 per month, it is only available to those with substantial resources, so does a drug like this violate the “spirit of sport”?
Is this how the peloton got so shockingly lean and seemed to be able to maintain that low body fat percentage since 2012?
@mcneese.chad Wasn’t sure where this should go so move it if it makes sense? 
